Fundraising Fox
AvroBio, Inc
1 known investors
Find your way into AvroBio, Inc
Sign up to see every warm intro you have to AvroBio, Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AvroBio, Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body. The modified cells differentiate into multiple cell types capable of crossing the blood-brain barrier to deliver treatment throughout the body and central nervous system.
Investors · 1
Frequently asked questions
- What does AvroBio, Inc do?
- AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body. The modified cells differentiate into multiple cell types capable of crossing the blood-brain barrier to deliver treatment throughout the body and central nervous system.
- Who are AvroBio, Inc's investors?
- AvroBio, Inc's investors include SV Health Investors.